These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 12244890)

  • 61. Ginkgo biloba leaf extract: review of biological actions and clinical applications.
    Yoshikawa T; Naito Y; Kondo M
    Antioxid Redox Signal; 1999; 1(4):469-80. PubMed ID: 11233145
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Meta-analysis of Ginkgo biloba Preparation for the Treatment of Alzheimer's Disease.
    Liao Z; Cheng L; Li X; Zhang M; Wang S; Huo R
    Clin Neuropharmacol; 2020; 43(4):93-99. PubMed ID: 32658034
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Chemical analysis, pharmacological activity and process optimization of the proportion of bilobalide and ginkgolides in Ginkgo biloba extract.
    Xiaoyan L; Li C; Liu T; Ke H; Gong X; Wang Q; Zhang J; Fan X
    J Pharm Biomed Anal; 2018 Oct; 160():46-54. PubMed ID: 30071391
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
    Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
    Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications.
    McKenna DJ; Jones K; Hughes K
    Altern Ther Health Med; 2001; 7(5):70-86, 88-90. PubMed ID: 11565403
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A 26-week analysis of a double-blind, placebo-controlled trial of the ginkgo biloba extract EGb 761 in dementia.
    Le Bars PL; Kieser M; Itil KZ
    Dement Geriatr Cogn Disord; 2000; 11(4):230-7. PubMed ID: 10867450
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of Ginkgo biloba on dementia: An overview of systematic reviews.
    Yuan Q; Wang CW; Shi J; Lin ZX
    J Ethnopharmacol; 2017 Jan; 195():1-9. PubMed ID: 27940086
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Ginkgo biloba precipitating epileptic seizures.
    Granger AS
    Age Ageing; 2001 Nov; 30(6):523-5. PubMed ID: 11742783
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Delay in progression of dependency and need of care of dementia patients treated with Ginkgo special extract EGb 761].
    Haan J; Hörr R
    Wien Med Wochenschr; 2004 Nov; 154(21-22):511-4. PubMed ID: 15638069
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Plant-based nutraceutical interventions against cognitive impairment and dementia: meta-analytic evidence of efficacy of a standardized Gingko biloba extract.
    Solfrizzi V; Panza F
    J Alzheimers Dis; 2015; 43(2):605-11. PubMed ID: 25352453
    [TBL] [Abstract][Full Text] [Related]  

  • 71. No alteration in the PFA-100 in vitro bleeding time induced by the Ginkgo biloba special extract, EGb 761, in elderly patients with mild cognitive impairment.
    Halil M; Cankurtaran M; Yavuz BB; Ozkayar N; Ulger Z; Dede DS; Shorbagi A; Buyukasik Y; Haznedaroglu IC; Arogul S
    Blood Coagul Fibrinolysis; 2005 Jul; 16(5):349-53. PubMed ID: 15970719
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ginkgo biloba (EGb 761): A Proprietary Leaf Extract of Ginkgo biloba Is Found to be Safe and Effective for Treating Dementia.
    Ross SM
    Holist Nurs Pract; 2015; 29(5):330-3. PubMed ID: 26263293
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical data in early intervention.
    Kasper S
    Int Psychogeriatr; 2012 Aug; 24 Suppl 1():S41-5. PubMed ID: 22784428
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Comparative anticancer and antioxidant activities of different ingredients of Ginkgo biloba extract (EGb 761).
    Feng X; Zhang L; Zhu H
    Planta Med; 2009 Jun; 75(8):792-6. PubMed ID: 19288403
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ginkgo biloba: indications, mechanisms, and safety.
    Diamond BJ; Bailey MR
    Psychiatr Clin North Am; 2013 Mar; 36(1):73-83. PubMed ID: 23538078
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Inhibition of platelet activating factor (PAF)-induced aggregation of human thrombocytes by ginkgolides: considerations on possible bleeding complications after oral intake of Ginkgo biloba extracts.
    Koch E
    Phytomedicine; 2005 Jan; 12(1-2):10-6. PubMed ID: 15693702
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.
    McCarney R; Fisher P; Iliffe S; van Haselen R; Griffin M; van der Meulen J; Warner J
    Int J Geriatr Psychiatry; 2008 Dec; 23(12):1222-30. PubMed ID: 18537221
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Spontaneous hyphema caused by Ginkgo biloba extract].
    Schneider C; Bord C; Misse P; Arnaud B; Schmitt-Bernard CF
    J Fr Ophtalmol; 2002 Sep; 25(7):731-2. PubMed ID: 12399731
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic efficacy of the Ginkgo special extract EGb761
    Müller WE; Eckert A; Eckert GP; Fink H; Friedland K; Gauthier S; Hoerr R; Ihl R; Kasper S; Möller HJ
    World J Biol Psychiatry; 2019 Mar; 20(3):173-189. PubMed ID: 28460580
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H
    Fortschr Neurol Psychiatr; 2009 Sep; 77(9):494-506. PubMed ID: 19621278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.